CPT1C and cancer: Recent studies found that cancer cells lacking the brain-specific metabolic enzyme carnitine palmitoyltransferase 1C (CPT1C) showed decreased fatty acid oxidation, reduced ATP generation and increased sensitivity to metabolic stress [60].